Compare ARK Genomic Revolution ETF (ARKG) vs Celsius Holdings, Inc. (CELH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Celsius Holdings, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while Celsius Holdings, Inc. trades at $29.54 (market cap $7.82B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Celsius Holdings, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | CELH | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $64.86 |
52-Week Low | $23.09 | $27.75 |
Market Cap | — | $7.82B |
Enterprise Value | — | $9.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Celsius Holdings (CELH) trades at $30.60, showing modest daily gains amid a broader bearish technical trend. The stock demonstrates strong fundamental growth with revenue surging from $654M in 2022 to $2.52B in 2025, though net margins compressed to 4.29%. Recent quarters consistently beat EPS estimates, and analyst sentiment remains overwhelmingly bullish with a $53.30 consensus target. However, negative cash flow trends and ongoing legal investigations present headwinds.
CELH offers significant upside potential based on analyst targets and robust revenue expansion, particularly in international markets. Key risks include margin pressure, high valuation multiples, and legal overhangs from shareholder investigations. The stock's investment case hinges on sustaining growth momentum while navigating competitive and operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Celsius Holdings, Inc.
Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.
Read more on CELH →
